We highly appreciate and acknowledge the immense value of open-access and democratization of education resources. Despite the program being fenced, we have scheduled some of the webinars and educative sessions to be open access so that anyone is able to join in and learn more about the different aspects of Antimicrobial Resistance.
Date: 10th October, 2022 Time: 7pm – 8:30 pm GMT+3
TOPIC: The Broken Pipeline of Antibiotics and Ongoing Efforts to Fix It
This webinar has been prepared in collaboration with CARB-X, a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world.
The webinar is part of the AMR Ambassadors Program open webinars and aims at educating us about the complex process behind antibiotic/diagnostics research, development and approval, challenges associated with it, and the negative implications. This will help us value the antibiotics already approved for use, and hopefully encourage us to educate others to appreciate these antibiotics, and actively take part in their conversation.
We will be inspired to support ongoing efforts, develop creative interventions in our own small ways, and hopefully trigger the interest of tertiary level students and early career professionals to pursue a further education or a career in drug discovery, and development.
Our Guest Speaker for the Webinar
Dr. Erin Duffy
Chief of Research & Development, CARB-X
Dr. Erin Duffy is the Chief of Research & Development at CARB-X, a global biopharmaceutical accelerator for the discovery and early development of products to prevent, diagnose and treat bacterial infections. Erin is an expert in drug discovery and problem solving in the antibiotic arena. Most of her professional growth was with Melinta Therapeutics (founded as Rib-X Pharmaceuticals), where over 17 years she became Executive Vice President, Chief Scientific Officer and R&D site head. Her entry into the pharmaceutical sector began with Pfizer Central Research. Erin’s formal training was at Yale University, where she completed a PhD in physical-organic chemistry and an HHMI postdoctoral fellowship in computational structural biology.